Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Jack Ishak

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Pharmacoeconomics|September 14, 2010
No head-to-head trial? simulate the missing armsJ Jaime Caro, K Jack Ishak
Journal of Comparative Effectiveness Research|November 19, 2013
Optimizing the design of pragmatic trials: key issues remainJ Jaime Caro, K Jack Ishak
Pharmacoeconomics|March 22, 2015
Simulation and matching-based approaches for indirect comparison of treatmentsK Jack Ishak, Irina Proskorovsky, Agnes Benedict
Pharmacoeconomics|May 16, 2013
Overview of parametric survival analysis for health-economic applicationsK Jack Ishak, Noemi Kreif, Agnes Benedict, et al.
Pharmacoeconomics|May 5, 2025
A Framework for Reliable, Transparent, and Reproducible Population-Adjusted Indirect ComparisonsK Jack Ishak, Conor Chandler, Fei Fei Liu, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 25, 2018
Alzheimer's disease Archimedes condition-event simulator: Development and validationAnuraag R Kansal, Ali Tafazzoli, K Jack Ishak, et al.
Pharmacoeconomics|April 21, 2010
Cost effectiveness of donepezil in the treatment of mild to moderate Alzheimer's disease: a UK evaluation using discrete-event simulationDenis Getsios, Steve Blume, K Jack Ishak, et al.
Statistics in Medicine|May 12, 2007
Impact of approximating or ignoring within-study covariances in multivariate meta-analysesK Jack Ishak, Robert W Platt, Lawrence Joseph, et al.
Clinical Therapeutics|August 12, 2008
Risk of discontinuation of risperidone after exposure to potentially interacting drugs: a nested case-control study in patients with schizophreniaK Jack Ishak, Ye Tan, Jennifer Glass, et al.
Medical Care|May 18, 2010
Bayesian meta-analyses for comparative effectiveness and informing coverage decisionsScott M Berry, K Jack Ishak, Bryan R Luce, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Pharmacoeconomics|September 14, 2010
No head-to-head trial? simulate the missing armsJ Jaime Caro, K Jack Ishak
Journal of Comparative Effectiveness Research|November 19, 2013
Optimizing the design of pragmatic trials: key issues remainJ Jaime Caro, K Jack Ishak
Pharmacoeconomics|March 22, 2015
Simulation and matching-based approaches for indirect comparison of treatmentsK Jack Ishak, Irina Proskorovsky, Agnes Benedict
Pharmacoeconomics|May 16, 2013
Overview of parametric survival analysis for health-economic applicationsK Jack Ishak, Noemi Kreif, Agnes Benedict, et al.
Pharmacoeconomics|May 5, 2025
A Framework for Reliable, Transparent, and Reproducible Population-Adjusted Indirect ComparisonsK Jack Ishak, Conor Chandler, Fei Fei Liu, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 25, 2018
Alzheimer's disease Archimedes condition-event simulator: Development and validationAnuraag R Kansal, Ali Tafazzoli, K Jack Ishak, et al.
Pharmacoeconomics|April 21, 2010
Cost effectiveness of donepezil in the treatment of mild to moderate Alzheimer's disease: a UK evaluation using discrete-event simulationDenis Getsios, Steve Blume, K Jack Ishak, et al.
Statistics in Medicine|May 12, 2007
Impact of approximating or ignoring within-study covariances in multivariate meta-analysesK Jack Ishak, Robert W Platt, Lawrence Joseph, et al.
Clinical Therapeutics|August 12, 2008
Risk of discontinuation of risperidone after exposure to potentially interacting drugs: a nested case-control study in patients with schizophreniaK Jack Ishak, Ye Tan, Jennifer Glass, et al.
Medical Care|May 18, 2010
Bayesian meta-analyses for comparative effectiveness and informing coverage decisionsScott M Berry, K Jack Ishak, Bryan R Luce, et al.
Pageof 3